Pharmetheus strengthens board of directors with key appointments

Pharmetheus, a leading company in biosimulation and biotech, is pleased to announce the appointment of two esteemed professionals to its Board of Directors, further enhancing the company's strategic vision and expertise. These appointments, effective immediately, represent an important step forward in Pharmetheus's commitment to innovation, growth, and excellence.


Joining the board are Sverre Bengtsson and Marie Sandström, both bringing extensive experience and invaluable insights to the Pharmetheus Board of Directors.

Sverre Bengtsson, has long experience from board positions and has a track record of bringing innovation to market.

Sverre Bengtsson, renowned for his product development acumen as founder at Viedoc, joins as a board member, strengthening the company’s strategic direction with his deep understanding of product innovation and commercialization.

Sverre Bengtsson comments on his appointment:

– I am deeply honored to join the Board of Directors at Pharmetheus. It is a privilege to contribute to the strategic direction of such an innovative company. I look forward to leveraging my experience in product development to drive impactful initiatives that will support Pharmetheus towards continued success.

Magnus Forsbrand, Chair of the Board at Pharmetheus, is more than content:

– We are honored to welcome Sverre Bengtsson to our Board of Directors. His extensive experience in technology development will be instrumental in guiding Pharmetheus in realizing the business strategy. Sverre’s proven track record of bringing innovative products to market and working in the field of technology will be very useful for the development of the company and its business. I am also delighted Marie Sandström has joined the board. Her long experience from the industry and the company will add vital perspectives to our group.

Marie Sandström, the former Chief Operating Officer (COO) of Pharmetheus, also joins the board, bringing with her knowledge and insights gained from years of dedicated service to the company and in the industry as a whole. With her deep understanding of Pharmetheus’s operations and a strong focus on client relationships, Marie Sandström’s appointment further strengthens the board’s ability to align corporate strategy with customer-centric values. Additionally, Marie Sandström will play a pivotal role in supporting the expansion of the business development initiatives, leveraging her extensive experience to drive strategic growth opportunities for Pharmetheus.

Joining the board is Dr. Marie Sandström, a co-founder of Pharmetheus, who has served both as CEO and COO.

The addition of Sverre Bengtsson and Marie Sandström to the board accentuates Pharmetheus’s commitment to a diverse and experienced leadership team. Their collective knowledge and strategic vision will play a crucial role in shaping the company’s future direction and to continue driving sustainable growth.

The board also thanks Joakim Nyberg for his service and wishes him well in his new role as Chief Technology Officer (CTO) in the Pharmetheus leadership team.